ESOPMay 29, 2026, 04:16 PM
Crescent Biopharma Grants 16,950 Stock Options to Employees
AI Summary
Crescent Biopharma, Inc. announced that its independent Compensation Committee approved the grant of options to purchase an aggregate of 16,950 ordinary shares to two non-executive employees. These equity inducement awards, approved on May 28, 2026, were material to the employees' acceptance of employment. The options have a 10-year term, an exercise price of $21.47, and vest over time, with one-fourth vesting on the first anniversary and the remainder vesting monthly thereafter.
Key Highlights
- Crescent Biopharma granted options to purchase 16,950 ordinary shares.
- Awards were granted to two non-executive employees as equity inducement.
- Options were approved on May 28, 2026, by the independent Compensation Committee.
- The exercise price for the options is $21.47 per share.
- Options have a 10-year term.
- Vesting occurs as 1/4th on the first anniversary and 1/48th monthly thereafter.
- Awards are material to the employees' acceptance of employment.
Price Impact
More from CBIO